Non-stimulant ADHD medication is a group of ADHD medicines that work differently from stimulants such as Adderall and Ritalin. For many people, a non-stimulant is a second option when a stimulant causes problems or does not work well for them, and the choice is one you make with a clinician.
What is a non-stimulant ADHD medication?
Stimulants are the medicines most people with ADHD start with. A 2004 review in the European Child & Adolescent Psychiatry journal, indexed by PubMed, calls stimulants the first-line medication and notes that 10 to 30% of children and adults with ADHD either do not respond to or do not tolerate stimulants. Non-stimulants are the alternative group.
As of October 2026, the Menninger Clinic’s blog says that unlike stimulants, atomoxetine “does not affect dopamine,” which is why it has little misuse potential and is not a controlled substance. The same blog lists these options:
| Option (brand) | How it is described | Status and cost notes | Who it may suit, and limits |
|---|---|---|---|
| Atomoxetine (Straterra) | Inhibits the reuptake of norepinephrine | First FDA-approved non-stimulant for ADHD, in 2002. Available as a generic, which the blog says decreases costs. | Not a controlled substance. Carries a boxed warning for children and adolescents (see below). |
| Viloxazine (Qelbree) | Works similarly to atomoxetine | FDA-approved for ADHD in April 2021. The blog says it is currently only available as Qelbree. | Not a controlled substance. Boxed warning for children and adolescents. Can raise blood pressure and heart rate. |
| Extended-release guanfacine (Intuniv) | An alpha-2 agonist | Indicated for ADHD in children and adolescents in 2009. Available as a generic. | Not a controlled substance. Watch for dizziness and lightheadedness, signs of low blood pressure. |
| Extended-release clonidine (Kapvay) | An alpha-2 agonist | Indicated for ADHD in children and adolescents in 2009. Available as a generic. | Not a controlled substance. Same blood pressure watch as guanfacine. |
| Modafinil and armodafinil (Provigil, Nuvigil) | Increases dopamine, similar to stimulants, but binds less tightly | Not FDA-approved for ADHD, so use is off-label. The blog says clinical trials have shown benefits for ADHD. | Controlled substances because of misuse risk. |
Check today’s price with your pharmacy or insurer before you plan around any option.
Do non-stimulants work as well as stimulants?
A 2024 meta-analysis in Neuroscience and Biobehavioral Reviews, listed on PubMed, pooled placebo-controlled trials of chronic methylphenidate (at least one week) and atomoxetine (at least three weeks). It measured executive-function tests, including reaction time, attention, inhibition and working memory, not overall ADHD symptom control. Its authors wrote that the two drugs have comparable effects on improving executive functions in people with ADHD, and the meta-regression found no drug differences on cognitive effects. It did not test other non-stimulants.
FHEA’s continuing-education resource for nurse practitioners says non-stimulant medication options for ADHD may not be as effective as psychostimulants for treating ADHD, though they are a good option for people who are not candidates for stimulants. Whether one option holds up better over years, and which one suits a given person, is still open.
Non-stimulants also take longer to work. The FHEA resource says non-stimulants take longer than stimulants to fully feel, and that it may take up to four weeks for a non-stimulant to kick in.
Are non-stimulant ADHD meds for kids, teens or kids with anxiety?
Children and teens need their own clinical decision. The Menninger Clinic’s blog says atomoxetine and viloxazine carry a boxed warning for children and adolescents, because some studies suggest they may increase suicidal ideation or behavior. It adds that whether they actually raise suicide risk is controversial, and that a 2016 review of available studies found no increased risk compared to stimulant medication, which does not have a comparable boxed warning.
Anxiety is a common pairing with ADHD. FHEA says around a fifth of people with ADHD also have a general anxiety or depression disorder, and that a stimulant can cause further nervousness and exacerbate anxiety symptoms. The blog says non-stimulants “do not increase anxiety and irritability.” Neither group is free of risk, so the balance for a child or teen is a conversation for their clinician.
A 2007 review in European Child & Adolescent Psychiatry, also on PubMed, looked at children with ADHD and tic disorders. It concluded that the preponderance of evidence suggests stimulants are safe and effective in this group, that a minority may see tics worsen, and that stimulants should be part of the discussion. For parents, the parent training for adhd guide covers the non-medication side of planning.
What are the side effects, and who should be careful?
The Menninger Clinic’s blog lists these side effects for each option:
| Medicine | Side effects listed |
|---|---|
| Stimulants (for comparison) | Increased anxiety and irritability (blog). Weight loss, insomnia, nervousness and headaches (FHEA). |
| Atomoxetine | Headache, insomnia, drowsiness, sweating, dry mouth, stomach upset, erectile dysfunction |
| Viloxazine | Increased blood pressure and heart rate, drowsiness, headache |
| Guanfacine or clonidine (extended-release) | Signs of low blood pressure, such as dizziness and lightheadedness |
| Modafinil or armodafinil | Headache is the most common side effect |
FHEA lists reasons some people should not take psychostimulants: an underlying heart problem, glaucoma, Tourette’s syndrome, a history of psychosis, severe anxiety and more. It also notes that some patients find stimulants “stop working or wear off too abruptly.” The blog’s own summary is direct: non-stimulants “pose their own risks and concerns.”
If sleep is part of the picture, the insomnia with adhd guide covers sleep, medication and routine together. For interactions with ADHD drugs, see stimulant medication interactions.
What about the Qelbree question?
Qelbree is the brand name for viloxazine. The Menninger Clinic’s blog says it was approved for ADHD in April 2021, works similarly to atomoxetine, has little misuse potential and is not a controlled substance. Its side effects include increased blood pressure and heart rate, drowsiness and headache. The blog says viloxazine is currently only available as Qelbree. Check with your pharmacist whether a generic exists now.
Can I manage ADHD without medication?
Medication is one part of care. FHEA says ADHD is best managed with a proper lifestyle that includes healthy eating, a strict sleep schedule and regular exercise, and that talk therapy can teach strategies for time management, organization and frustration tolerance. The adhd management beyond medication guide walks through these routes.
Supplements sold for focus are a different category. The National Center for Complementary and Integrative Health says, on its ginkgo page, that unlike drugs, dietary supplements are not approved by the U.S. Food and Drug Administration before they are sold to the public. The NIH Office of Dietary Supplements says researchers are studying whether omega-3 supplements may help lessen some symptoms of ADHD, and that more research is needed. Its omega-3 fact sheet covers the details. The Federal Trade Commission’s health products compliance guidance says health claims about supplements require competent and reliable scientific evidence.
How do I get an ADHD diagnosis?
A diagnosis comes from a clinician who assesses your symptoms, and that comes before any medicine choice. Start with your primary care doctor or a mental health clinician and ask for an ADHD assessment. Bring notes on where symptoms show up (school, work, home), how long they have been going on, and any anxiety, sleep or mood changes.
Your other questions, briefly
- Rebound effect of stimulants: the sources here do not describe a rebound effect. FHEA’s wear-off point above is the closest description. Ask your prescriber what happens as your dose wears off.
- Cold medicine after Adderall: ask your pharmacist how long to wait after an ADHD medicine before taking a cold product, and check the stimulant medication interactions guide.
- Long-term effects of Adderall: the 2024 meta-analysis covered at least one week for methylphenidate and at least three weeks for atomoxetine. Ask your prescriber what monitoring they would do over time.
- Sex drive on Adderall: erectile dysfunction is on the atomoxetine side effect list in the blog. Raise any change in sex drive with your prescriber rather than adjusting your medicine yourself.
- Japan, the UK, Canada and other countries: each country sets its own rules for ADHD medicines and controlled substances. Ask a pharmacist or your prescriber what applies where you live. In the U.S., the blog says the FDA regulates stimulants as controlled substances.
Questions to bring to your appointment
- Which options fit my age, my anxiety or heart history, and my other medicines?
- How long should I wait before judging whether a non-stimulant is working?
- What monitoring will you do, and what side effects should I report right away?
- What will this cost with my insurance, and which versions are generic?
Pick one next step this week: book an assessment or a medication review, and bring this list. Do not change or stop a medicine on your own.
By the Global MH Summit Research Team
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.